Cellectar selected to present new data from phase 2 clover-wam study in oral session at ash 2024

Ailawadhi, sikander, m.d., lead investigator, to present iopofosine i 131 efficacy and safety results from phase 2 clover-wam study

CLRB Ratings Summary

CLRB Quant Ranking